ArticleNeuropsychiatric disease and treatment2026
Associations Between Thalamic Gray Matter Volume and Psychomotor Symptoms in Major Depressive Disorder: A Voxel-Based Morphometry Study.
Article in Neuropsychiatric disease and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Major depressive disorder (MDD) is a heterogeneous disorder with diverse symptom profiles and treatment responses. Psychomotor retardation and agitation represent clinically relevant dimensions of MDD heterogeneity, but their neurobiological basis remains unclear. Given the role of the thalamus in motor regulation and affective processing, this study examined thalamic gray matter volume (GMV) differences among patients with MDD with predominant psychomotor retardation (MDD-R), patients with MDD with predominant psychomotor agitation (MDD-A), and healthy controls (HCs). Methods: Structural MRI data from the REST-meta-MDD consortium included 54 patients with MDD-A, 123 with MDD-R, and 122 HCs. Total, hemispheric, and 30 subregional thalamic GMV measures were extracted using voxel-based morphometry and the AAL3v1 atlas. ComBat harmonization was applied before analysis. Group differences were tested with analysis of covariance controlling for sex, age, education, and total gray matter volume. Exploratory partial Spearman correlations examined associations with psychomotor symptoms, HAMD(adj), and anxiety symptoms. Results: After FDR correction, significant group effects were limited to the bilateral ventral anterior nucleus (VA). Patients with MDD-R had greater bilateral VA GMV than HCs, whereas MDD-A did not differ from HCs. No direct MDD-A vs MDD-R difference survived FDR correction; only the left inferior pulvinar showed a nominal difference. Exploratory correlations linked several thalamic nuclei, including the reuniens nucleus, ventral posterolateral nucleus, lateral geniculate nucleus, and anteroventral nucleus, to psychomotor, depressive, or anxiety symptoms. Conclusion: MDD-R was associated with selective bilateral VA structural differences rather than widespread thalamic abnormalities. No direct thalamic GMV difference between MDD-A and MDD-R survived FDR correction. The exploratory symptom associations suggest that thalamic structure may relate to multidimensional clinical heterogeneity in MDD. These findings require replication given the cross-sectional design, unequal subgroup sizes, and incomplete medication data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.